TrialMolecular biology reports2025

The effects of nanocurcumin on immune-related factors in the ankylosing spondylitis patients: a double-blind, randomized, placebo-controlled clinical trial.

Halmat M Jaafar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.